Advertisement

Bone Tumors

  • Serge Weis
  • Michael Sonnberger
  • Andreas Dunzinger
  • Eva Voglmayr
  • Martin Aichholzer
  • Raimund Kleiser
  • Peter Strasser
Chapter
  • 402 Downloads

Abstract

Bone tumors are rare lesions affecting the skull and vertebral column. Benign bone-forming tumors include osteoma, osteoid osteoma, and osteoblastoma. Osteosarcoma is a malignant bone-forming tumor. Benign cartilage-forming tumors include osteochondroma, enchondroma, chondroma, and chondroblastoma. Chondrosarcoma is a malignant cartilage-forming tumor. Other bone tumors affecting the skull include fibrous dysplasia, chordoma as a notochordal tumor, giant cell tumor, and aneurysmal bone cyst.

Treatment includes depending on the diagnosis surgery, chemotherapy, and radiation.

Osteoma is composed of compact bone arising on the surface of the bone. It is made up of lamellar and woven bone with Haversian-like systems with a cortical-like architecture. Osteoma is a slow-growing lesion. Simple excision leads to excellent outcome with no recurrence.

Osteoid osteoma is characterized by small size (<2 cm), limited growth potential, and disproportionate pain, usually responsive to non-steroidal anti-inflammatory drugs. Radiologically, it presents as a lucent nidus (<1.5 cm) with surrounding sclerotic bone (lesions >1.5 cm are called osteoblastoma). The nidus (1–2 cm) is the central portion of the lesion with differentiated osteoblastic activity. Trabeculae of woven bone are rimmed by osteoblasts. Osteoid osteoma can be treated with radiofrequency ablation, curettage, or resection. Local recurrence rate ranges between 0 and 10%.

Osteosarcoma is a high-grade, intra-osseous, malignant neoplasm in which the neoplastic cells produce bone. Radiologically, it presents as an aggressive, ill-defined bone tumor with bone destruction and soft tumor mass. The neoplastic bone shows woven architecture, primitive disorganized trabeculae, and mineralized bone. Mutations in tumor suppressor genes, i.e., retinoblastoma gene (RB1) (66%) and TP53 gene, have been described. Wnt/catenin pathway, GSK-3ß/NF-κB, and cyclin-dependent kinases (CDKs) are involved. Osteosarcoma is treated by surgery, chemotherapy, and radiation.

Chondroma is a benign, well-circumscribed neoplasm composed of low-cellularity hyaline cartilage. The chondrocytes show fine granular eosinophilic cytoplasm, small round nuclei with condensed chromatin and are situated within sharp-edged lacunar spaces.

Chondrosarcoma is a malignant mesenchymal tumor with cartilaginous differentiation. Radiologically, it presents as a lytic tumor with chondroid calcifications. Histologically, neoplastic chondrocytes are of variable size with moderate amounts of eosinophilic cytoplasm showing cytologic atypia.

Molecular changes involve isocitrate dehydrogenase (IDH), tyrosine kinase, phosphoinositide 3-kinase/AKT/pathway, mammalian target of rapamycin (mTOR), tumor suppressor pathways: retinoblastoma and p53, and hedgehog pathway. Treatment: aggressive curettage to surgical resection followed by radiation.

Fibrous dysplasia is a benign, medullary, fibro-osseous lesion, which may involve one or more bones. Radiologically, it presents as tumor-like growth of fibrous tissue replacing normal bone and causing bone deformation. Molecular changes include the presence of stimulatory alpha subunit of G protein (Gs) in dysplastic bone lesions, mutations in Gsalpha, constitutive elevation in cAMP level induced by the Gsalpha mutations which lead to alterations in the expression of several target genes whose promoters contain cAMP-responsive elements, such as c-fos, c-jun, Il-6, and Il-11. Treatment ranges from observation to surgical removal. Malignant transformation is possible.

Chordoma is a malignant tumor showing notochordal differentiation. It usually arises within bones of the axial skeleton. Histologically, it consists of large epitheloid cells with clear eosinophilic cytoplasm or vacuolated cytoplasm, i.e., physaliphorous cells. The cells are arranged in small ribbons and cords embedded in abundant extracellular matrix. The tumor originates from remnants of embryonic notochord along the spine, more frequently at the skull base and sacrum. Treatment consists of surgery followed by radiation therapy. Prognosis is affected by tumor location, size, and resectability. Local progression is possible. Metastatic spread ranges between 5 and 43%. The tumor can resist chemotherapy and radiotherapy.

Giant cell tumor is composed of cytologically benign, oval, or polyhedral mononuclear cells that are admixed with numerous, evenly distributed, osteoclast-like cells. Radiologically, it presents as a well-defined osteolytic lesion usually without sclerotic margin. Molecular changes involve receptor activator of nuclear factor-κB ligand (RANKL) as well as proteases, including numerous matrix metalloproteinases. Giant cell tumor is treated by surgery, radiation, and RANK ligand inhibitors. Local recurrence rate is of about 25%.

Aneurysmal bone cyst is a destructive, expansile benign tumor with blood-filled cystic spaces. The blood-filled, cystic spaces are separated by fibrous septae which is composed of moderately dense, cellular proliferation of bland fibroblasts, multinucleated, osteoclast-like giant cells, and reactive woven bone rimmed by osteoblasts. Recurrence rate is low; malignant transformation possible (rare).

Selected References

  1. Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, Gonzalez MV, Baldini N, Garcia-Castro J, Rodriguez R (2016) Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies. Stem Cells Int 2016:3631764.  https://doi.org/10.1155/2016/3631764Google Scholar
  2. Allen SD, Saifuddin A (2003) Imaging of intra-articular osteoid osteoma. Clin Radiol 58(11):845–852Google Scholar
  3. Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM (2014) Giant cell tumor of bone. Orthopedics 37(2):112–120.  https://doi.org/10.3928/01477447-20140124-08Google Scholar
  4. Amaral L, Chiurciu M, Almeida JR, Ferreira NF, Mendonca R, Lima SS (2003) MR imaging for evaluation of lesions of the cranial vault: a pictorial essay. Arq Neuropsiquiatr 61(3a):521–532Google Scholar
  5. Anitha N, Sankari SL, Malathi L, Karthick R (2015) Fibrous dysplasia-recent concepts. J Pharm Bioallied Sci 7(Suppl 1):S171–S172.  https://doi.org/10.4103/0975-7406.155892Google Scholar
  6. Atesok KI, Alman BA, Schemitsch EH, Peyser A, Mankin H (2011) Osteoid osteoma and osteoblastoma. J Am Acad Orthop Surg 19(11):678–689Google Scholar
  7. Athanasou NA, Bansal M, Forsyth R, Reid RP, Sapi Z (2013) Giant cell tumour of bone. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 321–324Google Scholar
  8. Athwal P, Stock H (2014) Osteoid osteoma: a pictorial review. Conn Med 78(4):233–235Google Scholar
  9. Awad M, Gogos AJ, Kaye AH (2016) Skull base chondrosarcoma. J Clin Neurosci 24:1–5.  https://doi.org/10.1016/j.jocn.2015.10.029Google Scholar
  10. Baumhoer D, Bras J (2013) Osteoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, p 276Google Scholar
  11. Bielack SS, Hecker-Nolting S, Blattmann C, Kager L (2016) Advances in the management of osteosarcoma. F1000Res 5:2767.  https://doi.org/10.12688/f1000research.9465.1Google Scholar
  12. Bloch OG, Jian BJ, Yang I, Han SJ, Aranda D, Ahn BJ, Parsa AT (2009) A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci 16(12):1547–1551.  https://doi.org/10.1016/j.jocn.2009.05.003Google Scholar
  13. Bloch O, Sughrue ME, Mills SA, Parsa AT (2011) Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy. J Clin Neurosci 18(7):881–885.  https://doi.org/10.1016/j.jocn.2010.09.025Google Scholar
  14. Boscainos PJ, Cousins GR, Kulshreshtha R, Oliver TB, Papagelopoulos PJ (2013) Osteoid osteoma. Orthopedics 36(10):792–800.  https://doi.org/10.3928/01477447-20130920-10Google Scholar
  15. Botter SM, Neri D, Fuchs B (2014) Recent advances in osteosarcoma. Curr Opin Pharmacol 16:15–23.  https://doi.org/10.1016/j.coph.2014.02.002Google Scholar
  16. Boyce AM, Bhattacharyya N, Collins MT (2013) Fibrous dysplasia and fibroblast growth factor-23 regulation. Curr Osteoporos Rep 11(2):65–71.  https://doi.org/10.1007/s11914-013-0144-5Google Scholar
  17. Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR Jr (2013) Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics 33(1):197–211.  https://doi.org/10.1148/rg.331125089Google Scholar
  18. Chang L, Shrestha S, LaChaud G, Scott MA, James AW (2015) Review of microRNA in osteosarcoma and chondrosarcoma. Med Oncol 32(6):613.  https://doi.org/10.1007/s12032-015-0613-zGoogle Scholar
  19. Chong VF, Khoo JB, Fan YF (2002) Fibrous dysplasia involving the base of the skull. Am J Roentgenol 178(3):717–720.  https://doi.org/10.2214/ajr.178.3.1780717Google Scholar
  20. Collins MT (2006) Spectrum and natural history of fibrous dysplasia of bone. J Bone Miner Res 21(Suppl 2):P99–p104.  https://doi.org/10.1359/jbmr.06s219Google Scholar
  21. Cortini M, Avnet S, Baldini N (2017) Mesenchymal stroma: role in osteosarcoma progression. Cancer Lett 405:90–99.  https://doi.org/10.1016/j.canlet.2017.07.024Google Scholar
  22. Cottalorda J, Bourelle S (2007) Modern concepts of primary aneurysmal bone cyst. Arch Orthop Trauma Surg 127(2):105–114.  https://doi.org/10.1007/s00402-006-0223-5Google Scholar
  23. Cowan RW, Singh G (2013) Giant cell tumor of bone: a basic science perspective. Bone 52(1):238–246.  https://doi.org/10.1016/j.bone.2012.10.002Google Scholar
  24. de Andrea CE, Bridge JA, Schiller A (2013) Osteoblastoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 279–280Google Scholar
  25. Diaz RJ, Cusimano MD (2011) The biological basis for modern treatment of chordoma. J Neurooncol 104(2):411–422.  https://doi.org/10.1007/s11060-011-0559-8Google Scholar
  26. DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 87(8):1848–1864.  https://doi.org/10.2106/jbjs.d.02942Google Scholar
  27. Douis H, Saifuddin A (2013) The imaging of cartilaginous bone tumours. II. Chondrosarcoma. Skeletal Radiol 42(5):611–626.  https://doi.org/10.1007/s00256-012-1521-3Google Scholar
  28. Durfee RA, Mohammed M, Luu HH (2016) Review of osteosarcoma and current management. Rheumatol Ther 3(2):221–243.  https://doi.org/10.1007/s40744-016-0046-yGoogle Scholar
  29. Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O (2003) Comprehensive review of intracranial chordoma. Radiographics 23(4):995–1009.  https://doi.org/10.1148/rg.234025176Google Scholar
  30. Evola FR, Costarella L, Pavone V, Caff G, Cannavo L, Sessa A, Avondo S, Sessa G (2017) Biomarkers of osteosarcoma, chondrosarcoma, and ewing sarcoma. Front Pharmacol 8:150.  https://doi.org/10.3389/fphar.2017.00150Google Scholar
  31. Feller L, Wood NH, Khammissa RA, Lemmer J, Raubenheimer EJ (2009) The nature of fibrous dysplasia. Head Face Med 5:22.  https://doi.org/10.1186/1746-160x-5-22Google Scholar
  32. Fernandes GL, Natal MRC, da Cruz CLP, Nascif RL, Tsuno NSG, Tsuno MY (2017) Primary osteosarcoma of the cranial vault. Radiol Bras 50(4):263–265.  https://doi.org/10.1590/0100-3984.1914-2014Google Scholar
  33. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, Hunter TB (2004) Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. Am J Roentgenol 182(6):1389–1398.  https://doi.org/10.2214/ajr.182.6.1821389Google Scholar
  34. Flanagan AM, Yamaguchi T (2013) Chordoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 328–329Google Scholar
  35. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) WHO classification of tumors of soft tissue and bone, 4th edn. IARC, LyonGoogle Scholar
  36. Florez H, Peris P, Guanabens N (2016) Fibrous dysplasia. Clinical review and therapeutic management. Med Clin 147(12):547–553.  https://doi.org/10.1016/j.medcli.2016.07.030Google Scholar
  37. Fountas KN, Stamatiou S, Barbanis S, Kourtopoulos H (2008) Intracranial falx chondroma: literature review and a case report. Clin Neurol Neurosurg 110(1):8–13.  https://doi.org/10.1016/j.clineuro.2007.08.020Google Scholar
  38. Georgalas C, Goudakos J, Fokkens WJ (2011) Osteoma of the skull base and sinuses. Otolaryngol Clin North Am 44(4):875–890, vii.  https://doi.org/10.1016/j.otc.2011.06.008Google Scholar
  39. Gulluoglu S, Turksoy O, Kuskucu A, Ture U, Bayrak OF (2016) The molecular aspects of chordoma. Neurosurg Rev 39(2):185–196.; discussion 196.  https://doi.org/10.1007/s10143-015-0663-xGoogle Scholar
  40. He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ, Feng JX (2014) Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev 15(15):5967–5976Google Scholar
  41. Hogendoorn PCW, Bovée JVMG, Nielsen GP (2013) Chondrosarcoma (grades I-III), including primary and secondary variants and periosteal chondrosarcoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 264–268Google Scholar
  42. Hondar Wu HT, Chen W, Lee O, Chang CY (2006) Imaging and pathological correlation of soft-tissue chondroma: a serial five-case study and literature review. Clin Imaging 30(1):32–36.  https://doi.org/10.1016/j.clinimag.2005.01.027Google Scholar
  43. Horvai A, Klein M (2013) Osteoid osteoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 277–278Google Scholar
  44. Iyer RS, Chapman T, Chew FS (2012) Pediatric bone imaging: diagnostic imaging of osteoid osteoma. Am J Roentgenol 198(5):1039–1052.  https://doi.org/10.2214/ajr.10.7313Google Scholar
  45. Jamil N, Howie S, Salter DM (2010) Therapeutic molecular targets in human chondrosarcoma. Int J Exp Pathol 91(5):387–393.  https://doi.org/10.1111/j.1365-2613.2010.00749.xGoogle Scholar
  46. Kan P, Schmidt MH (2008) Osteoid osteoma and osteoblastoma of the spine. Neurosurg Clin N Am 19(1):65–70.  https://doi.org/10.1016/j.nec.2007.09.003Google Scholar
  47. Kim Y, Nizami S, Goto H, Lee FY (2012) Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg 4(2):107–116.  https://doi.org/10.4055/cios.2012.4.2.107Google Scholar
  48. Kitamura Y, Sasaki H, Yoshida K (2017) Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma. Brain Tumor Pathol 34(2):78–90.  https://doi.org/10.1007/s10014-017-0283-yGoogle Scholar
  49. Kunimatsu A, Kunimatsu N (2017) Skull base tumors and tumor-like lesions: a pictorial review. Pol J Radiol 82:398–409.  https://doi.org/10.12659/pjr.901937Google Scholar
  50. Kushlinskii NE, Fridman MV, Braga EA (2016) Molecular mechanisms and microRNAs in osteosarcoma pathogenesis. Biochem Biokhim 81(4):315–328.  https://doi.org/10.1134/s0006297916040027Google Scholar
  51. Leddy LR, Holmes RE (2014) Chondrosarcoma of bone. Cancer Treat Res 162:117–130.  https://doi.org/10.1007/978-3-319-07323-1_6Google Scholar
  52. Lee EH, Shafi M, Hui JH (2006) Osteoid osteoma: a current review. J Pediatr Orthop 26(5):695–700.  https://doi.org/10.1097/01.bpo.0000233807.80046.7cGoogle Scholar
  53. Lietman SA, Levine MA (2013) Fibrous dysplasia. Pediatr Endocrinol Rev 10(Suppl 2):389–396Google Scholar
  54. Lin SP, Fang YC, Chu DC, Chang YC, Hsu CI (2007) Characteristics of cranial aneurysmal bone cyst on computed tomography and magnetic resonance imaging. J Formos Med Assoc 106(3):255–259.  https://doi.org/10.1016/s0929-6646(09)60249-7Google Scholar
  55. Lin YH, Jewell BE, Gingold J, Lu L, Zhao R, Wang LL, Lee DF (2017) Osteosarcoma: molecular pathogenesis and iPSC modeling. Trends Mol Med 23(8):737–755.  https://doi.org/10.1016/j.molmed.2017.06.004Google Scholar
  56. Lindsey BA, Markel JE, Kleinerman ES (2017) Osteosarcoma overview. Rheumatol Ther 4(1):25–43.  https://doi.org/10.1007/s40744-016-0050-2Google Scholar
  57. Lisle DA, Monsour PA, Maskiell CD (2008) Imaging of craniofacial fibrous dysplasia. J Med Imaging Radiat Oncol 52(4):325–332.  https://doi.org/10.1111/j.1440-1673.2008.01963.xGoogle Scholar
  58. Liu P, Shen JK, Xu J, Trahan CA, Hornicek FJ, Duan Z (2016) Aberrant DNA methylations in chondrosarcoma. Epigenomics 8(11):1519–1525.  https://doi.org/10.2217/epi-2016-0071Google Scholar
  59. Liu X, Zhang Z, Deng C, Tian Y, Ma X (2017) Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis. Oncotarget 8(37):62769–62779.  https://doi.org/10.18632/oncotarget.19370Google Scholar
  60. Logie CI, Walker EA, Forsberg JA, Potter BK, Murphey MD (2013) Chondrosarcoma: a diagnostic imager’s guide to decision making and patient management. Semin Musculoskelet Radiol 17(2):101–115.  https://doi.org/10.1055/s-0033-1342967Google Scholar
  61. Lu ZH, Cao WH, Qian WX (2013) Aggressive osteoblastoma of the temporal bone: a case report and review of the literature. Clin Imaging 37(2):386–389.  https://doi.org/10.1016/j.clinimag.2012.05.017Google Scholar
  62. Lucas DR, Bridge JA (2013) Chondromas: enchondroma, periosteal chondroma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 252–254Google Scholar
  63. Ma Y, Xu W, Yin H, Huang Q, Liu T, Yang X, Wei H, Xiao J (2015) Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review. Eur Spine J 24(8):1754–1760.  https://doi.org/10.1007/s00586-015-3834-0Google Scholar
  64. MacDonald-Jankowski D (2009) Fibrous dysplasia: a systematic review. Dentomaxillofac Radiol 38(4):196–215.  https://doi.org/10.1259/dmfr/16645318Google Scholar
  65. Maclean FM, Soo MY, Ng T (2005) Chordoma: radiological-pathological correlation. Australas Radiol 49(4):261–268.  https://doi.org/10.1111/j.1440-1673.2005.01433.xGoogle Scholar
  66. Marie PJ (2001) Cellular and molecular basis of fibrous dysplasia. Histol Histopathol 16(3):981–988Google Scholar
  67. Mascard E, Gomez-Brouchet A, Lambot K (2015) Bone cysts: unicameral and aneurysmal bone cyst. Orthopaed Traumatol Surg Res 101(1 Suppl):S119–S127.  https://doi.org/10.1016/j.otsr.2014.06.031Google Scholar
  68. Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN (2017) Giant cell tumor of bone revisited. SICOT-J 3:54.  https://doi.org/10.1051/sicotj/2017041Google Scholar
  69. McLoughlin GS, Sciubba DM, Wolinsky JP (2008) Chondroma/chondrosarcoma of the spine. Neurosurg Clin N Am 19(1):57–63.  https://doi.org/10.1016/j.nec.2007.09.007Google Scholar
  70. Mendenhall WM, Zlotecki RA, Gibbs CP, Reith JD, Scarborough MT, Mendenhall NP (2006a) Aneurysmal bone cyst. Am J Clin Oncol 29(3):311–315.  https://doi.org/10.1097/01.coc.0000204403.13451.52Google Scholar
  71. Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP (2006b) Giant cell tumor of bone. Am J Clin Oncol 29(1):96–99.  https://doi.org/10.1097/01.coc.0000195089.11620.b7Google Scholar
  72. Morrow JJ, Khanna C (2015) Osteosarcoma genetics and epigenetics: emerging biology and candidate therapies. Crit Rev Oncog 20(3-4):173–197Google Scholar
  73. Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH (2003) From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics 23(5):1245–1278.  https://doi.org/10.1148/rg.235035134Google Scholar
  74. Nielsen GP, Fletcher JA, Oliveira AM (2013) Aneurysmal bone cyst. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 348–349Google Scholar
  75. Nielsen GP, Rosenberg AE, Deshpande V, Hornicek FJ, Kattapuram SV, Rosenthal DI (2017) Diagnostic pathology: bone, 2nd edn. Elsevier, AmsterdamGoogle Scholar
  76. Ozkal E, Erongun U, Cakir B, Acar O, Uygun A, Bitik M (1996) CT and MR imaging of vertebral osteoblastoma. A report of two cases. Clin Imaging 20(1):37–41Google Scholar
  77. Pelargos PE, Nagasawa DT, Ung N, Chung LK, Thill K, Tenn S, Gopen Q, Yang I (2015) Clinical characteristics and diagnostic imaging of cranial osteoblastoma. J Clin Neurosci 22(3):445–449.  https://doi.org/10.1016/j.jocn.2014.10.002Google Scholar
  78. Pereira HM, Marchiori E, Severo A (2014) Magnetic resonance imaging aspects of giant-cell tumours of bone. J Med Imaging Radiat Oncol 58(6):674–678.  https://doi.org/10.1111/1754-9485.12249Google Scholar
  79. Polychronidou G, Karavasilis V, Pollack SM, Huang PH, Lee A, Jones RL (2017) Novel therapeutic approaches in chondrosarcoma. Future Oncol 13(7):637–648.  https://doi.org/10.2217/fon-2016-0226Google Scholar
  80. Pridgeon MG, Grohar PJ, Steensma MR, Williams BO (2017) Wnt signaling in ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. Curr Osteoporos Rep 15(4):239–246.  https://doi.org/10.1007/s11914-017-0377-9Google Scholar
  81. Pu F, Chen F, Shao Z (2016) MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma. Tumour Biol.  https://doi.org/10.1007/s13277-016-5468-1
  82. Rapp TB, Ward JP, Alaia MJ (2012) Aneurysmal bone cyst. J Am Acad Orthop Surg 20(4):233–241.  https://doi.org/10.5435/jaaos-20-04-233Google Scholar
  83. Riminucci M, Robey PG, Bianco P (2007) The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev 4(Suppl 4):401–411Google Scholar
  84. Rosenberg AE, Cleton-Jansen A-M, de Pinieux G, Deyrup AT, Hauben E, Squire J (2013) Conventional osteosarcoma. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 282–288Google Scholar
  85. Ruggieri P, McLeod RA, Unni KK, Sim FH (1996) Osteoblastoma. Orthopedics 19(7):621–624Google Scholar
  86. Saccomanni B (2008) Aneurysmal bone cyst of spine: a review of literature. Arch Orthop Trauma Surg 128(10):1145–1147.  https://doi.org/10.1007/s00402-007-0477-6Google Scholar
  87. Scotter A (2004) Giant cell tumor. Radiol Technol 75(5):394–396Google Scholar
  88. Serra M, Hattinger CM (2017) The pharmacogenomics of osteosarcoma. Pharmacogenomics J 17(1):11–20.  https://doi.org/10.1038/tpj.2016.45Google Scholar
  89. Shah ZK, Peh WC, Koh WL, Shek TW (2005) Magnetic resonance imaging appearances of fibrous dysplasia. Br J Radiol 78(936):1104–1115.  https://doi.org/10.1259/bjr/73852511Google Scholar
  90. Siegal GP, Bianco P, Dal Cin P (2013) Fibrous dysplasia. In: Fletcher CDM, Bridge JA, Hogendorn PCW, Mertens F (eds) WHO classification of tumours of soft tissue and bone. IARC, Lyon, pp 352–353Google Scholar
  91. Sobti A, Agrawal P, Agarwala S, Agarwal M (2016) Giant cell tumor of bone—an overview. Arch Bone Joint Surg 4(1):2–9Google Scholar
  92. Soldatos T, McCarthy EF, Attar S, Carrino JA, Fayad LM (2011) Imaging features of chondrosarcoma. J Comput Assist Tomogr 35(4):504–511.  https://doi.org/10.1097/RCT.0b013e31822048ffGoogle Scholar
  93. Speetjens FM, de Jong Y, Gelderblom H, Bovee JV (2016) Molecular oncogenesis of chondrosarcoma: impact for targeted treatment. Curr Opin Oncol 28(4):314–322.  https://doi.org/10.1097/cco.0000000000000300Google Scholar
  94. Sprengel SD, Weber MA, Lehner B, Rehnitz C (2015) Osteoidosteoma. From diagnosis to treatment. Radiologe 55(6):479–486.  https://doi.org/10.1007/s00117-014-2805-5Google Scholar
  95. Stacy GS, Peabody TD, Dixon LB (2003) Mimics on radiography of giant cell tumor of bone. Am J Roentgenol 181(6):1583–1589.  https://doi.org/10.2214/ajr.181.6.1811583Google Scholar
  96. Tamura R, Miwa T, Shimizu K, Mizutani K, Tomita H, Yamane N, Tominaga T, Sasaki S (2016) Giant cell tumor of the skull: review of the literature. J Neurol Surg A Cent Eur Neurosurg 77(3):239–246.  https://doi.org/10.1055/s-0035-1554808Google Scholar
  97. Terek RM (2006) Recent advances in the basic science of chondrosarcoma. Orthop Clin North Am 37(1):9–14.  https://doi.org/10.1016/j.ocl.2005.09.001Google Scholar
  98. Turcotte RE (2006) Giant cell tumor of bone. Orthop Clin North Am 37(1):35–51.  https://doi.org/10.1016/j.ocl.2005.08.005Google Scholar
  99. Van Gompel JJ, Janus JR (2015) Chordoma and chondrosarcoma. Otolaryngol Clin North Am 48(3):501–514.  https://doi.org/10.1016/j.otc.2015.02.009Google Scholar
  100. Vigorita VJ (2016) Orthopaedic pathology, 3rd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  101. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13(2):e69–e76.  https://doi.org/10.1016/s1470-2045(11)70337-0Google Scholar
  102. Wu PF, Tang JY, Li KH (2015) RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects. Tumour Biol 36(2):495–501.  https://doi.org/10.1007/s13277-015-3094-yGoogle Scholar
  103. Yakkioui Y, van Overbeeke JJ, Santegoeds R, van Engeland M, Temel Y (2014) Chordoma: the entity. Biochim Biophys Acta 1846(2):655–669.  https://doi.org/10.1016/j.bbcan.2014.07.012Google Scholar
  104. Yarmish G, Klein MJ, Landa J, Lefkowitz RA, Hwang S (2010) Imaging characteristics of primary osteosarcoma: nonconventional subtypes. Radiographics 30(6):1653–1672.  https://doi.org/10.1148/rg.306105524Google Scholar
  105. Yu X, Li Z (2015) Epigenetic deregulations in chordoma. Cell Prolif 48(5):497–502.  https://doi.org/10.1111/cpr.12204Google Scholar
  106. Zhang W, Duan N, Song T, Li Z, Zhang C, Chen X (2017) The emerging roles of forkhead box (FOX) proteins in osteosarcoma. J Cancer 8(9):1619–1628.  https://doi.org/10.7150/jca.18778Google Scholar
  107. Zou MX, Huang W, Wang XB, Li J, Lv GH, Deng YW (2015) Prognostic factors in spinal chordoma: a systematic review. Clin Neurol Neurosurg 139:110–118.  https://doi.org/10.1016/j.clineuro.2015.09.012Google Scholar
  108. Zou MX, Lv GH, Zhang QS, Wang SF, Li J, Wang XB (2018) Prognostic factors in skull base chordoma: a systematic literature review and meta-analysis. World Neurosurg 109:307–327.  https://doi.org/10.1016/j.wneu.2017.10.010Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Serge Weis
    • 1
  • Michael Sonnberger
    • 2
  • Andreas Dunzinger
    • 3
  • Eva Voglmayr
    • 2
  • Martin Aichholzer
    • 4
  • Raimund Kleiser
    • 2
  • Peter Strasser
    • 5
  1. 1.Division of Neuropathology, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  2. 2.Department of Neuroradiology, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  3. 3.Department of Neuro-Nuclear Medicine, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  4. 4.Department of Neurosurgery, Neuromed CampusKepler University Hospital, Johannes Kepler UniversityLinzAustria
  5. 5.PMU University Institute for Medical & Chemical Laboratory DiagnosticsSalzburgAustria

Personalised recommendations